To explore the relationship between the predicted p53 status and the response to RT in vivo, we analyzed an independent dataset consisting of 35 patient-derived xenograft (PDX) models that closely mimic the genetic and phenotypic characteristics of glioblastoma (GBM) patients [56]. The gene discussed is TP53; the disease is glioblastoma.